PTIE - Pain Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development7,6159,1769,100
Selling General and Administrative4,3345,7815,102
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-11,949-14,957-14,202
Income from Continuing Operations
Total Other Income/Expenses Net3810757
Earnings Before Interest and Taxes-11,911-14,850-14,145
Interest Expense---
Income Before Tax-11,911-14,850-14,145
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-11,911-14,850-14,145
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-11,911-14,850-14,145
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-11,911-14,850-14,145